Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

An Open Label, Two Way Crossover Study to Evaluate the Bioavailability and Clinical Tolerability of a Novel Sublingual Wafer Formulation of Ketamine in Healthy Male Volunteers

To see complete record on, please visit this link

Id: NCT01377831

Organisation Name: iX Biopharma Ltd.

Overal Status: Completed

Start Date: June 2011

Last Update: March 10, 2015

Lead Sponsor: iX Biopharma Ltd.

Brief Summary: To determine the rate and extent of of absorption of racemic ketamine from sublingual wafer

  • Pain

Total execution time in seconds: 0.27353596687317